Integration of multiparametric MRI into active surveillance of prostate cancer.

Published

Journal Article (Review)

Prostate cancer is the most common noncutaneous cancer in men though many men will not die of this disease and may not require definitive treatment. Active surveillance (AS) is an increasingly utilized potential solution to the issue of overtreatment of prostate cancer. Traditionally, prostate cancer patients have been stratified into risk groups based on clinical stage on digital rectal examination, prostate-specific antigen and biopsy Gleason score, though each of these variables has significant limitations. This review will discuss the potential role for prostate multiparametric MRI and targeted biopsy techniques incorporating MRI in the selection of candidates for AS, monitoring patients on AS and as triggers for definitive treatment.

Full Text

Duke Authors

Cited Authors

  • Holtz, JN; Tay, KJ; Polascik, TJ; Gupta, RT

Published Date

  • November 2016

Published In

Volume / Issue

  • 12 / 21

Start / End Page

  • 2513 - 2529

PubMed ID

  • 27322161

Pubmed Central ID

  • 27322161

Electronic International Standard Serial Number (EISSN)

  • 1744-8301

Digital Object Identifier (DOI)

  • 10.2217/fon-2016-0142

Language

  • eng

Conference Location

  • England